Literature DB >> 5142052

Prevention of staphylococcal shunt infections by continuous vancomycin prophylaxis.

A J Morris, R T Bilinsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5142052     DOI： 10.1097/00000441-197108000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  12 in total

Review 1.  Vancomycin- and erythromycin-induced hearing loss in humans.

Authors:  R E Brummett; K E Fox
Journal:  Antimicrob Agents Chemother       Date:  1989-06       Impact factor: 5.191

2.  Mycobacterium avium-M. intracellulare and Acquired Immunodeficiency Syndrome.

Authors:  E Wolinsky; C R Horsburgh; D L Cohn; R B Roberts; H Masur; R Miller; A Y Tsang; M D Iseman
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

Review 3.  Drug prescribing in renal failure.

Authors:  W M Bennett
Journal:  Drugs       Date:  1979-02       Impact factor: 9.546

4.  Sensitive bioassay for vancomycin.

Authors:  C A Walker; B Kopp
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

5.  Vancomycin: renewed interest in an old drug.

Authors:  B B Farber
Journal:  Eur J Clin Microbiol       Date:  1984-02       Impact factor: 3.267

6.  Comparison of fluorescence polarization immunoassay and bioassay of vancomycin.

Authors:  D J Pohlod; L D Saravolatz; M M Somerville
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

7.  Pharmacokinetics of vancomycin in patients with various degrees of renal function.

Authors:  G R Matzke; R W McGory; C E Halstenson; W F Keane
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

8.  Pharmacokinetics of vancomycin in patients undergoing continuous ambulatory peritoneal dialysis.

Authors:  R D Blevins; C E Halstenson; N G Salem; G R Matzke
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

Review 9.  Pharmacokinetic optimisation of vancomycin therapy.

Authors:  W G Leader; M H Chandler; M Castiglia
Journal:  Clin Pharmacokinet       Date:  1995-04       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.